Ajinomoto Co., Inc.

Is Ajinomoto publicly traded?

Yes. Ajinomoto Co., Inc. trades on the Tokyo Stock Exchange under stock code 2802 and is a constituent of the Nikkei 225 index.

When was Ajinomoto founded?

The business began in 1909 with the commercialization of AJI-NO-MOTO umami seasoning, following Kikunae Ikeda's 1908 discovery of umami. The corporate entity was formally incorporated in 1925 and later took the product's name.

What does Ajinomoto make besides seasoning?

The company produces frozen foods, packaged coffee through subsidiary AGF, amino acids for food and pharmaceutical use, contract drug manufacturing services, sweeteners, sports nutrition products, and Ajinomoto Build-up Film, an insulation material used in advanced semiconductor packaging.

What was Ajinomoto's revenue in fiscal 2025?

Consolidated sales were JPY 1,583.7 billion for the year ended March 31, 2026, up 3.5% year on year, with business profit of JPY 181.1 billion, up 13.7%. Both figures were records.

Who leads Ajinomoto?

Shigeo Nakamura serves as Representative Executive Officer and President, having taken over in 2025. The company operates under a Japanese corporate governance structure separating board oversight from executive management.

Where is Ajinomoto headquartered?

The company is headquartered in Chuo City, Tokyo, Japan, with factories and subsidiaries across Asia, the Americas, and Europe.

The company traces to a 1908 scientific result. Professor Kikunae Ikeda of Tokyo Imperial University isolated glutamate as the source of the savory taste in kombu dashi and named the taste umami. Businessman Saburosuke Suzuki II acquired commercialization rights, and the seasoning AJI-NO-MOTO launched in 1909. The corporate entity took shape around the product and was formally incorporated in 1925.

Early decades were a marketing build: consumers had to be taught what umami seasoning did, so the company invested in cooking education and expanded first into Taiwan and China, then across Asia and into the Americas. Postwar recovery turned it into a multinational, with local MSG plants built in Thailand, Brazil, the Philippines, and elsewhere, a model of producing where it sells that still defines the footprint.

Diversification built the modern group. Frozen foods became a major Japanese category for the company from the 1970s. Amino acid fermentation technology developed for seasoning production seeded a chemicals and healthcare business: feed-use amino acids, pharmaceutical-grade amino acids, sweeteners, and eventually drug manufacturing services. The 1973 joint venture that became Ajinomoto General Foods, now Ajinomoto AGF, made the company a major player in Japanese packaged coffee through Blendy and Maxim.

The materials story is a later chapter with outsized profit impact. Ajinomoto Build-up Film, developed from the company's chemistry work in the late 1990s, became the standard insulation layer in the semiconductor substrates used for CPUs and high-performance chips, tying a food company to the AI-era chip supply chain. What began as byproduct chemistry from amino acid research now contributes a high-margin business that few outside the industry associate with the seasoning name.

Recent history includes both portfolio pruning and record results. The company sold Ajinomoto Althea, a U.S. contract manufacturing unit, during fiscal 2025, while electronic materials and bio-pharma services drove Healthcare and Others profit up 45%. Fiscal 2025, ended March 31, 2026, set records: sales of JPY 1,583.7 billion, up 3.5%, and business profit of JPY 181.1 billion, up 13.7%. The fiscal 2026 forecast targets JPY 1,723 billion in sales and JPY 197 billion in business profit.

Leadership changed in 2025, when Shigeo Nakamura became Representative Executive Officer and President, succeeding Taro Fujie.

Ajinomoto publishes an annual ASV (Ajinomoto Group Shared Value) report covering environmental, social, and nutrition commitments. The company has adopted science-based emissions targets and reports progress on sustainable sourcing for key raw materials, including RSPO membership for palm oil.

Group-level commitments include reducing environmental impact across its fermentation and manufacturing base, improving nutrition outcomes through product formulation, and extending healthy life expectancy, a stated target of helping one billion people. The fermentation-based production model for MSG and amino acids uses plant feedstocks rather than petrochemical synthesis.

As with other large food companies, the group's nutrition positioning draws periodic criticism over the salt and additive content of convenience products, though no independent greenwashing enforcement actions against the company were identified as of October 2026.

MSG legacy: The company's signature ingredient carried decades of health stigma in Western markets following a 1968 medical journal letter that spawned the term Chinese restaurant syndrome. Subsequent controlled research and reviews by the FDA, WHO, and EU bodies found MSG safe at normal intake levels, and the episode is now treated in food journalism as a cautionary case about unsupported food scares.

North American tariffs: Fiscal 2025 results took a direct hit in Frozen Foods, where profit fell 35% partly due to temporary tariff impacts in North America, illustrating the company's exposure to trade policy.

Labeling scrutiny: The company periodically faces consumer advocacy pressure around additive labeling in various markets, though MSG remains an approved ingredient under Codex and major national regulatory systems.